News

Press Releases

Asuragen to Launch the AmplideX® PCR/CE DMPK Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference
Asuragen to Present at 2018 ACMG Annual Clinical Genetics Meeting
Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer
Asuragen to Present at 29th Annual Piper Jaffray Healthcare Conference
Asuragen to Present at Upcoming 2017 Association for Molecular Pathology (AMP) Annual Meeting
Asuragen to Present at 2017 American Society of Human Genetics (ASHG) Conference
Asuragen CEO to Speak at 2017 World CDx Summit
Asuragen Expands QuantideX® qPCR BCR-ABL Portfolio for Monitoring Molecular Response in Chronic Myeloid Leukemia
Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio
Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space

About

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close